Quick Takeaways
- ForGrowth III PA B.V. filed SCHEDULE 13G for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT).
- Disclosed ownership: 7.4%.
- Date of event: 23 Oct 2025.
ForGrowth III PA B.V. - 23 Oct 2025 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT)
- Filing Manager
- ForGrowth III PA B.V.
- Reporting Manager
- ForGrowth III PA B.V.
- Symbol
- RAPT
- Shares outstanding
- 24,774,770 shares
- Disclosed Ownership
- 1,833,333 shares
- Ownership
- 7.4%
- Form type
- SCHEDULE 13G
- Filing time
- 29 Oct 2025, 19:51:46 UTC
- Date of event
- 23 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ForGrowth III PA B.V. disclosed 7.4% ownership in RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT) on 23 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Oct 2025, 19:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ForGrowth III PA B.V. | 7.4% | 1,833,333 | 0 | 1,833,333 | /s/ V. van Houten and /s/ G.J. Mulder | V. van Houten and G.J. Mulder, Directors of its Director | |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.4% | 1,833,333 | 0 | 1,833,333 | /s/ V. van Houten and /s/ G.J. Mulder | V. van Houten and G.J. Mulder, Directors of its Director | |
| Forbion Growth III Management B.V. | 7.4% | 1,833,333 | 0 | 1,833,333 | /s/ V. van Houten and /s/ G.J. Mulder | V. van Houten and G.J. Mulder, Directors |